§ 866.3050. Beta-glucan serological assays.
111 words·~1 min read·
/us/cfr/t21/s§ 866.3050·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Identification. Beta-glucan serological assays are devices that consist of antigens or proteases used in serological assays. The device is intended for use for the presumptive diagnosis of fungal infection. The assay is indicated for use in patients with symptoms of, or medical conditions predisposing the patient to invasive fungal infection. The device can be used as an aid in the diagnosis of deep seated mycoses and fungemias.
(b)Classification. Class II (special controls). The special control is FDA's guidance document entitled “Class II Special Controls Guidance Document: Serological Assays for the Detection of Beta-Glucan.” See § 866.1(e) for the availability of this guidance document. [69 FR 56936, Sept. 23, 2004]
Connections1 cite this
Cited by 1 section
register
Citation graph
cites case law
§ 866.3050
Beta-glucan serological assays.
Fed. Reg.×1
Cites 0Cited by 1 across 1 source